OverviewChartNewsTraderScreen

LABORATORIOS FARMACEUT./  ES0157261019  /

Lang & Schwarz
13/05/2024  23:00:17 Chg. +0.90 Volume Bid23:00:17 Ask23:00:17 High Low
84.45EUR +1.08% -
Turnover: -		 84.45Bid Size: - 84.55Ask Size: - 84.60 82.40
TeleTrader 06:23 Suzuki: Currency stability key for Japan
GlobeNewswire 06:00 SPEE3D LAUNCHES EXPEDITIONARY MANUFACTURING UNIT (EMU) – THE COMPLETE MOBILE ADDITIVE MANUFACTURING ...
TeleTrader 05:43 Israel intercepts drone near eastern border
TeleTrader 05:24 Russia downs 'several air targets' over Belgorod
GlobeNewswire 05:01 MKS Instruments Announces Pricing of Upsized Private Offering of $1.2 Billion of 1.25% Convertible S...
GlobeNewswire 05:00 WASD Studios announces its custom WEB3 Gamefi initiative
TeleTrader 04:46 Blinken arrives in Kiev to show US support
TeleTrader 04:30 Walmart to reportedly cut jobs, move staff to central hubs
GlobeNewswire 04:10 Kilmer Sports Ventures Enters into Exclusive Negotiations to Acquire French Professional Football Cl...
TeleTrader 04:03 Asia-Pacific mixed after Japanese data
Newsfile Corp 03:57 Design Firm MARGARITA BRAVA Releases Interview
GlobeNewswire 03:50 Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 03:00 Infinera to Announce Preliminary Fiscal First Quarter 2024 Financial Results on May 14, 2024
TeleTrader 03:00 US allegedly thinks Israel has enough troops for Rafah incursion
GlobeNewswire 03:00 GLOBAL LIFE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Bee...
GlobeNewswire 02:29 AKRO INVESTOR ALERT: Edelson Lechtzin LLP Urges Akero Therapeutics, Inc. (NASDAQ: AKRO) Shareholders...
TeleTrader 02:25 US destroys two Houthi drones, one anti-ship missile
GlobeNewswire 02:06 MBUU INVESTOR ALERT: Edelson Lechtzin LLP Urges Malibu Boats, Inc. (NASDAQ: MBUU) Shareholders With ...
GlobeNewswire 02:02 GCC Announces Dividend Payment
GlobeNewswire 02:00 ROSEN, A LEADING LAW FIRM, Encourages Rivian Automotive, Inc. Investors With Losses in Excess of $10...
GlobeNewswire 02:00 HUTCHMED Initiates the RAPHAEL Registrational Phase III Trial of HMPL-306 for Patients with IDH1- an...
GlobeNewswire 02:00 HUTCHMED Initiates Phase II/III Trial of the Combination of Surufatinib and Camrelizumab for Treatme...
GlobeNewswire 01:55 StakingFarm Gains Traction Amid Ark Invest’s Removal of Staking from Ethereum ETF Proposal
TeleTrader 01:50 Japan's producer prices rise 0.9% in April
TeleTrader 01:46 Hezbollah claims responsibility for 7 attacks on Israel